148 related articles for article (PubMed ID: 2165238)
1. [Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
Vanhoof R; Nyssen HJ; Nulens E; Roebben E; Hubrechts JM
Pathol Biol (Paris); 1990 Jun; 38(6):634-7. PubMed ID: 2165238
[TBL] [Abstract][Full Text] [Related]
2. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
Le Noc P; Croize J; Le Noc D
Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
4. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
Ronco E; Vacheron F; Orabona A
Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
[TBL] [Abstract][Full Text] [Related]
5. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
[TBL] [Abstract][Full Text] [Related]
6. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Spencer RC
Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
Bakhtiar M; Selwyn S
Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa.
Vurma-Rapp U; Kayser FH
Eur J Clin Microbiol; 1986 Jun; 5(3):292-6. PubMed ID: 3091365
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
11. [Activity of cefpirome against bacteria isolated from hospitalized patients].
Fernández A; Herran I; de Mier C; Marcenac FM
Medicina (B Aires); 1989; 49(4):373-8. PubMed ID: 2487748
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
Lewis RP; Meyer RD; Kraus LL
Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antibacterial activity of cefpirome in combination with 4 aminoglycosides and 2 fluoroquinolones].
Le Noc P; Croize J; Bryskier A; Le Noc D
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):762-7. PubMed ID: 3141888
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
Wundt W; Lange KP; Baumgärtner M
Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Baumgärtner M; Müller HP; Wundt W
Arzneimittelforschung; 1983; 33(12):1615-9. PubMed ID: 6320836
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
[TBL] [Abstract][Full Text] [Related]
17. Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.
Digranes A; Dibb WL; Benonisen E
Chemotherapy; 1984; 30(2):113-8. PubMed ID: 6365480
[TBL] [Abstract][Full Text] [Related]
18. [Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
Duval J; Soussy CJ
Presse Med; 1984 Mar; 13(13):763-7. PubMed ID: 6231591
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of cefepime and four extended-spectrum beta-lactams on 1,251 aminoglycoside-resistant gram-negative hospital strains.
Vanhoof R; Nulens E; Nyssen HJ; Hannecart-Pokorni E
Chemotherapy; 1992; 38(4):225-31. PubMed ID: 1473361
[TBL] [Abstract][Full Text] [Related]
20. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Acred P; Ryan DM; Sowa MA; Watts CM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
